We proceeded through the integration of different MRI sequences for the prediction of the MGMT promoter methylation status, developing several models based on either radiomic features analyzed with a RF classifier or deep learning-based approaches, including joint fusion models, using different tumor areas. Here, MGMT is linked to neoplasm.